SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM

The current price of 1349 is 2.08 HKD — it has decreased by 0.48% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM stocks are traded under the ticker 1349.

SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.

1349 stock is 1.45% volatile and has beta coefficient of 0.84. Check out the list of the most volatile stocks — is SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM there?

Yes, you can track SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM financials in yearly and quarterly reports right on TradingView.

1349 stock has fallen by 0.95% compared to the previous week, the month change is a 8.37% fall, over the last year SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM has showed a 36.97% decrease.

1349 net income for the last quarter is ‪20.25 M‬ HKD, while the quarter before that showed ‪23.16 M‬ HKD of net income which accounts for −12.56% change. Track more SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM financial stats to get the full picture.

Yes, 1349 dividends are paid annually. The last dividend per share was 0.08 HKD. As of today, Dividend Yield (TTM)% is 3.82%. Tracking SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM dividends might help you take more informed decisions.

SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM dividend yield was 2.97% in 2023, and payout ratio reached 65.23%. The year before the numbers were 2.30% and 51.22% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.

Like other stocks, 1349 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM stock right from TradingView charts — choose your broker and connect to your account.

1349 reached its all-time high on Jun 1, 2015 with the price of 12.64 HKD, and its all-time low was 0.01 HKD and was reached on Mar 3, 2008.
See other stocks reaching their highest and lowest prices.

As of Apr 18, 2024, the company has 948.00 employees. See our rating of the largest employees — is SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM stock shows the sell signal. See more of SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM EBITDA is ‪148.41 M‬ HKD, and current EBITDA margin is 16.45%. See more stats in SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM financial statements.